Anthropometric characteristics and ovarian cancer risk and survival

go back to reference SEER (2017) Cancer Stat Facts: Ovarian Cancer SEER (2017) Cancer Stat Facts: Ovarian Cancer

go back to reference Bookman MA (2012) First-line chemotherapy in epithelial ovarian cancer. Clin Obstet Gynecol 55:96–113CrossRefPubMed Bookman MA (2012) First-line chemotherapy in epithelial ovarian cancer. Clin Obstet Gynecol 55:96–113CrossRefPubMed

go back to reference Bae HS, Kim HJ, Hong JH, Lee JK, Lee NW, Song JY (2014) Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis. J Ovarian Res 7:41CrossRefPubMedPubMedCentral Bae HS, Kim HJ, Hong JH, Lee JK, Lee NW, Song JY (2014) Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis. J Ovarian Res 7:41CrossRefPubMedPubMedCentral

go back to reference Cancer CGoESoO (2012) Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med, 9:e1001200CrossRef Cancer CGoESoO (2012) Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med, 9:e1001200CrossRef

go back to reference Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Hogdall E, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Hoyo C, Moorman P, Weber RP, Cramer DW, Vitonis AF, Bandera EV, Olson SH, Rodriguez-Rodriguez L, King M, Brinton LA, Yang H, Garcia-Closas M, Lissowska J, Anton-Culver H, Ziogas A, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Webb PM, A.C.S.O. Cancer., A.O.C.S. Group, O.C.A. Consortium (2013) Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium, Endocr Relat Cancer, 20:251–262CrossRefPubMed Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Hogdall E, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Hoyo C, Moorman P, Weber RP, Cramer DW, Vitonis AF, Bandera EV, Olson SH, Rodriguez-Rodriguez L, King M, Brinton LA, Yang H, Garcia-Closas M, Lissowska J, Anton-Culver H, Ziogas A, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Webb PM, A.C.S.O. Cancer., A.O.C.S. Group, O.C.A. Consortium (2013) Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium, Endocr Relat Cancer, 20:251–262CrossRefPubMed

go back to reference Nagle CM, Dixon SC, Jensen A, Kjaer SK, Modugno F, deFazio A, Fereday S, Hung J, Johnatty SE, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Van Nieuwenhuysen E, Lambrechts S, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Goodman MT, Ness RB, Moysich K, Heitz F, du Bois A, Harter P, Schwaab I, Matsuo K, Hosono S, Goode EL, Vierkant RA, Larson MC, Fridley BL, Høgdall C, Schildkraut JM, Weber RP, Cramer DW, Terry KL, Bandera EV, Paddock L, Rodriguez-Rodriguez L, Wentzensen N, Yang HP, Brinton LA, Lissowska J, Høgdall E, Lundvall L, Whittemore A, McGuire V, Sieh W, Rothstein J, Sutphen R, Anton-Culver H, Ziogas A, Pearce CL, Wu AH, Webb PM, A.O.C.S. Group, O.C.A. Consortium (2015) Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. Br J Cancer, 113:817–826CrossRefPubMedPubMedCentral Nagle CM, Dixon SC, Jensen A, Kjaer SK, Modugno F, deFazio A, Fereday S, Hung J, Johnatty SE, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Van Nieuwenhuysen E, Lambrechts S, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Goodman MT, Ness RB, Moysich K, Heitz F, du Bois A, Harter P, Schwaab I, Matsuo K, Hosono S, Goode EL, Vierkant RA, Larson MC, Fridley BL, Høgdall C, Schildkraut JM, Weber RP, Cramer DW, Terry KL, Bandera EV, Paddock L, Rodriguez-Rodriguez L, Wentzensen N, Yang HP, Brinton LA, Lissowska J, Høgdall E, Lundvall L, Whittemore A, McGuire V, Sieh W, Rothstein J, Sutphen R, Anton-Culver H, Ziogas A, Pearce CL, Wu AH, Webb PM, A.O.C.S. Group, O.C.A. Consortium (2015) Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. Br J Cancer, 113:817–826CrossRefPubMedPubMedCentral

go back to reference Kabat GC, Heo M, Kamensky V, Miller AB, Rohan TE (2013) Adult height in relation to risk of cancer in a cohort of Canadian women. Int J Cancer 132:1125–1132CrossRefPubMed Kabat GC, Heo M, Kamensky V, Miller AB, Rohan TE (2013) Adult height in relation to risk of cancer in a cohort of Canadian women. Int J Cancer 132:1125–1132CrossRefPubMed

go back to reference Kabat GC, Anderson ML, Heo M, Hosgood HD, Kamensky V, Bea JW, Hou L, Lane DS, Wactawski-Wende J, Manson JE, Rohan TE (2013) Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 22:1353–1363CrossRefPubMed Kabat GC, Anderson ML, Heo M, Hosgood HD, Kamensky V, Bea JW, Hou L, Lane DS, Wactawski-Wende J, Manson JE, Rohan TE (2013) Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 22:1353–1363CrossRefPubMed

go back to reference Aune D, Navarro Rosenblatt DA, Chan DS, Abar L, Vingeliene S, Vieira AR, Greenwood DC, Norat T (2015) Anthropometric factors and ovarian cancer risk: a systematic review and nonlinear dose-response meta-analysis of prospective studies. Int J Cancer 136:1888–1898CrossRefPubMed Aune D, Navarro Rosenblatt DA, Chan DS, Abar L, Vingeliene S, Vieira AR, Greenwood DC, Norat T (2015) Anthropometric factors and ovarian cancer risk: a systematic review and nonlinear dose-response meta-analysis of prospective studies. Int J Cancer 136:1888–1898CrossRefPubMed

go back to reference World Cancer Research Fund/American Institute for Cancer Research, Ovarian Cancer 2014 Report: Food, nutrition, physical activity, and the prevention of ovarian cancer, AICR, Washington DC, 2014 World Cancer Research Fund/American Institute for Cancer Research, Ovarian Cancer 2014 Report: Food, nutrition, physical activity, and the prevention of ovarian cancer, AICR, Washington DC, 2014

go back to reference Kotsopoulos J, Moody JR, Fan I, Rosen B, Risch HA, McLaughlin JR, Sun P, Narod SA (2012) Height, weight, BMI and ovarian cancer survival. Gynecol Oncol 127:83–87CrossRefPubMed Kotsopoulos J, Moody JR, Fan I, Rosen B, Risch HA, McLaughlin JR, Sun P, Narod SA (2012) Height, weight, BMI and ovarian cancer survival. Gynecol Oncol 127:83–87CrossRefPubMed

go back to reference Wirén S, Häggström C, Ulmer H, Manjer J, Bjørge T, Nagel G, Johansen D, Hallmans G, Engeland A, Concin H, Jonsson H, Selmer R, Tretli S, Stocks T, Stattin P (2014) Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control 25:151–159CrossRefPubMed Wirén S, Häggström C, Ulmer H, Manjer J, Bjørge T, Nagel G, Johansen D, Hallmans G, Engeland A, Concin H, Jonsson H, Selmer R, Tretli S, Stocks T, Stattin P (2014) Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control 25:151–159CrossRefPubMed

go back to reference Song YM, Sung J (2008) Adult height and the risk of mortality in South Korean women. Am J Epidemiol 168:497–505CrossRefPubMed Song YM, Sung J (2008) Adult height and the risk of mortality in South Korean women. Am J Epidemiol 168:497–505CrossRefPubMed

go back to reference Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ (2002) Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 11:822–828PubMed Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ (2002) Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 11:822–828PubMed

go back to reference Bandera EV, Qin B, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Schildkraut JM (2016) Obesity, weight gain, and ovarian cancer risk in African American women. Int J Cancer 139:593–600CrossRefPubMedPubMedCentral Bandera EV, Qin B, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Schildkraut JM (2016) Obesity, weight gain, and ovarian cancer risk in African American women. Int J Cancer 139:593–600CrossRefPubMedPubMedCentral

go back to reference Ma X, Beeghly-Fadiel A, Shu XO, Li H, Yang G, Gao YT, Zheng W (2013) Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women’s Health Study. Br J Cancer 109:751–755CrossRefPubMedPubMedCentral Ma X, Beeghly-Fadiel A, Shu XO, Li H, Yang G, Gao YT, Zheng W (2013) Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women’s Health Study. Br J Cancer 109:751–755CrossRefPubMedPubMedCentral

go back to reference Schouten LJ, Goldbohm RA, van den Brandt PA (2003) Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol 157:424–433CrossRefPubMed Schouten LJ, Goldbohm RA, van den Brandt PA (2003) Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol 157:424–433CrossRefPubMed

go back to reference Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE, Hankinson SE (2002) Obesity, weight gain, and ovarian cancer. Obstet Gynecol 100:288–296PubMed Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE, Hankinson SE (2002) Obesity, weight gain, and ovarian cancer. Obstet Gynecol 100:288–296PubMed

go back to reference Jonsson F, Wolk A, Pedersen NL, Lichtenstein P, Terry P, Ahlbom A, Feychting M (2003) Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 106:594–599CrossRefPubMed Jonsson F, Wolk A, Pedersen NL, Lichtenstein P, Terry P, Ahlbom A, Feychting M (2003) Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 106:594–599CrossRefPubMed

go back to reference Lubin F, Chetrit A, Freedman LS, Alfandary E, Fishler Y, Nitzan H, Zultan A, Modan B (2003) Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol 157:113–120CrossRefPubMed Lubin F, Chetrit A, Freedman LS, Alfandary E, Fishler Y, Nitzan H, Zultan A, Modan B (2003) Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol 157:113–120CrossRefPubMed

go back to reference Lo-Ciganic WH, Zgibor JC, Bunker CH, Moysich KB, Edwards RP, Ness RB (2012) Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. Epidemiology 23:311–319CrossRefPubMedPubMedCentral Lo-Ciganic WH, Zgibor JC, Bunker CH, Moysich KB, Edwards RP, Ness RB (2012) Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. Epidemiology 23:311–319CrossRefPubMedPubMedCentral

go back to reference Ness RB, Dodge RC, Edwards RP, Baker JA, Moysich KB (2011) Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. Ann Epidemiol 21:188–196CrossRefPubMed Ness RB, Dodge RC, Edwards RP, Baker JA, Moysich KB (2011) Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. Ann Epidemiol 21:188–196CrossRefPubMed

go back to reference Minlikeeva AN, Freudenheim JL, Lo-Ciganic WH, Eng KH, Friel G, Diergaarde B, Modugno F, Cannioto R, Gower E, Szender JB, Grzankowski K, Odunsi K, Ness RB, Moysich KB (2015) Use of Common Analgesics Is Not Associated with Ovarian Cancer Survival. Cancer Epidemiol Biomarkers Prev 24:1291–1294CrossRefPubMedPubMedCentral Minlikeeva AN, Freudenheim JL, Lo-Ciganic WH, Eng KH, Friel G, Diergaarde B, Modugno F, Cannioto R, Gower E, Szender JB, Grzankowski K, Odunsi K, Ness RB, Moysich KB (2015) Use of Common Analgesics Is Not Associated with Ovarian Cancer Survival. Cancer Epidemiol Biomarkers Prev 24:1291–1294CrossRefPubMedPubMedCentral

go back to reference McGee J, Kotsopoulos J, Lubinski J, Lynch HT, Rosen B, Tung N, Kim-Sing C, Karlan B, Foulkes WD, Ainsworth P, Ghadirian P, Senter L, Eisen A, Sun P, Narod SA, H.B.C.C.S. Group (2012) Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers. Obesity 20:1288–1292CrossRefPubMed McGee J, Kotsopoulos J, Lubinski J, Lynch HT, Rosen B, Tung N, Kim-Sing C, Karlan B, Foulkes WD, Ainsworth P, Ghadirian P, Senter L, Eisen A, Sun P, Narod SA, H.B.C.C.S. Group (2012) Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers. Obesity 20:1288–1292CrossRefPubMed

go back to reference Greer JB, Modugno F, Ness RB, Allen GO (2006) Anthropometry and the risk of epithelial ovarian cancer. Cancer 106:2247–2257CrossRefPubMed Greer JB, Modugno F, Ness RB, Allen GO (2006) Anthropometry and the risk of epithelial ovarian cancer. Cancer 106:2247–2257CrossRefPubMed

go back to reference Physical status: the use and interpretation of anthropometry (1995) Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854:1–452 Physical status: the use and interpretation of anthropometry (1995) Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854:1–452

go back to reference Collaboration ERF (2012) Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol 41:1419–1433CrossRef Collaboration ERF (2012) Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol 41:1419–1433CrossRef

go back to reference Batty GD, Barzi F, Woodward M, Jamrozik K, Woo J, Kim HC, Ueshima H, Huxley RR, A.P.C.S. Collaboration (2010) Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration. Ann Oncol 21:646–654CrossRefPubMed Batty GD, Barzi F, Woodward M, Jamrozik K, Woo J, Kim HC, Ueshima H, Huxley RR, A.P.C.S. Collaboration (2010) Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration. Ann Oncol 21:646–654CrossRefPubMed

go back to reference Rosenfeld RG (2003) Insulin-like growth factors and the basis of growth. N Engl J Med 349:2184–2186CrossRefPubMed Rosenfeld RG (2003) Insulin-like growth factors and the basis of growth. N Engl J Med 349:2184–2186CrossRefPubMed

go back to reference Lukanova A, Kaaks R (2005) Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 14:98–107PubMed Lukanova A, Kaaks R (2005) Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 14:98–107PubMed

go back to reference Wang HS, Chard T (1999) IGFs and IGF-binding proteins in the regulation of human ovarian and endometrial function. J Endocrinol 161:1–13CrossRefPubMed Wang HS, Chard T (1999) IGFs and IGF-binding proteins in the regulation of human ovarian and endometrial function. J Endocrinol 161:1–13CrossRefPubMed

go back to reference Zhang B, Shu XO, Delahanty RJ, Zeng C, Michailidou K, Bolla MK, Wang Q, Dennis J, Wen W, Long J, Li C, Dunning AM, Chang-Claude J, Shah M, Perkins BJ, Czene K, Darabi H, Eriksson M, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Neven P, Wildiers H, Floris G, Schmidt MK, Rookus MA, van den Hurk K, de Kort WL, Couch FJ, Olson JE, Hallberg E, Vachon C, Rudolph A, Seibold P, Flesch-Janys D, Peto J, Dos-Santos-Silva I, Fletcher O, Johnson N, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Li J, Humphreys K, Brand J, Guénel P, Truong T, Cordina-Duverger E, Menegaux F, Burwinkel B, Marme F, Yang R, Surowy H, Benitez J, Zamora MP, Perez JI, Cox A, Cross SS, Reed MW, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Chenevix-Trench G, Haiman CA, Henderson BE, Schumacher F, Marchand LL, Lindblom A, Margolin S, Hooning MJ, Martens JW, Tilanus-Linthorst MM, Collée JM, Hopper JL, Southey MC, Tsimiklis H, Apicella C, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Giles GG, Milne RL, McLean C, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow AJ, Ashworth A, Orr N, Jones M, Figueroa J, Garcia-Closas M, Brinton L, Lissowska J, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Brauch H, Brüning T, Ko YD, Peterlongo P, Manoukian S, Bonanni B, Radice P, Bogdanova N, Antonenkova N, Dörk T, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubiński J, Jaworska-Bieniek K, Durda K, Hamann U, Torres D, Schmutzler RK, Neuhausen SL, Anton-Culver H, Kristensen VN, Grenaker Alnæs GI, Pierce BL, Kraft P, Peters U, Lindstrom S, Seminara D, Burgess S, Ahsan H, Whittemore AS, John EM, Gammon MD, Malone KE, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, Alonso MR, Álvarez N, Herrero D, Pharoah PD, Simard J, Hall P, Hunter DJ, Easton DF, Zheng W, A.s.O.S.G. kConFab Investigators (2015) D. Project, Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization, J Natl Cancer Inst 107 Zhang B, Shu XO, Delahanty RJ, Zeng C, Michailidou K, Bolla MK, Wang Q, Dennis J, Wen W, Long J, Li C, Dunning AM, Chang-Claude J, Shah M, Perkins BJ, Czene K, Darabi H, Eriksson M, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Neven P, Wildiers H, Floris G, Schmidt MK, Rookus MA, van den Hurk K, de Kort WL, Couch FJ, Olson JE, Hallberg E, Vachon C, Rudolph A, Seibold P, Flesch-Janys D, Peto J, Dos-Santos-Silva I, Fletcher O, Johnson N, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Li J, Humphreys K, Brand J, Guénel P, Truong T, Cordina-Duverger E, Menegaux F, Burwinkel B, Marme F, Yang R, Surowy H, Benitez J, Zamora MP, Perez JI, Cox A, Cross SS, Reed MW, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Chenevix-Trench G, Haiman CA, Henderson BE, Schumacher F, Marchand LL, Lindblom A, Margolin S, Hooning MJ, Martens JW, Tilanus-Linthorst MM, Collée JM, Hopper JL, Southey MC, Tsimiklis H, Apicella C, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Giles GG, Milne RL, McLean C, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow AJ, Ashworth A, Orr N, Jones M, Figueroa J, Garcia-Closas M, Brinton L, Lissowska J, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Brauch H, Brüning T, Ko YD, Peterlongo P, Manoukian S, Bonanni B, Radice P, Bogdanova N, Antonenkova N, Dörk T, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubiński J, Jaworska-Bieniek K, Durda K, Hamann U, Torres D, Schmutzler RK, Neuhausen SL, Anton-Culver H, Kristensen VN, Grenaker Alnæs GI, Pierce BL, Kraft P, Peters U, Lindstrom S, Seminara D, Burgess S, Ahsan H, Whittemore AS, John EM, Gammon MD, Malone KE, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, Alonso MR, Álvarez N, Herrero D, Pharoah PD, Simard J, Hall P, Hunter DJ, Easton DF, Zheng W, A.s.O.S.G. kConFab Investigators (2015) D. Project, Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization, J Natl Cancer Inst 107

go back to reference Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505–518CrossRefPubMed Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505–518CrossRefPubMed

go back to reference Resnicoff M, Ambrose D, Coppola D, Rubin R (1993) Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab Investig 756–760 Resnicoff M, Ambrose D, Coppola D, Rubin R (1993) Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab Investig 756–760

go back to reference Chakrabarty S, Kondratick L (2006) Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells. Cancer Biol Ther 5:189–197CrossRefPubMed Chakrabarty S, Kondratick L (2006) Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells. Cancer Biol Ther 5:189–197CrossRefPubMed

go back to reference Lee EJ, Mircean C, Shmulevich I, Wang H, Liu J, Niemistö A, Kavanagh JJ, Lee JH, Zhang W (2005) Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer 4:7CrossRefPubMedPubMedCentral Lee EJ, Mircean C, Shmulevich I, Wang H, Liu J, Niemistö A, Kavanagh JJ, Lee JH, Zhang W (2005) Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer 4:7CrossRefPubMedPubMedCentral

go back to reference King SM, Modi DA, Eddie SL, Burdette JE (2013) Insulin and insulin-like growth factor signaling increases proliferation and hyperplasia of the ovarian surface epithelium and decreases follicular integrity through upregulation of the PI3-kinase pathway. J Ovarian Res 6:12CrossRefPubMedPubMedCentral King SM, Modi DA, Eddie SL, Burdette JE (2013) Insulin and insulin-like growth factor signaling increases proliferation and hyperplasia of the ovarian surface epithelium and decreases follicular integrity through upregulation of the PI3-kinase pathway. J Ovarian Res 6:12CrossRefPubMedPubMedCentral

go back to reference Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V, M.W.S. Collaborators (2011) Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 12:785–794CrossRefPubMedPubMedCentral Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V, M.W.S. Collaborators (2011) Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 12:785–794CrossRefPubMedPubMedCentral

go back to reference Baer HJ, Hankinson SE, Tworoger SS (2008) Body size in early life and risk of epithelial ovarian cancer: results from the Nurses’ Health Studies. Br J Cancer 99:1916–1922CrossRefPubMedPubMedCentral Baer HJ, Hankinson SE, Tworoger SS (2008) Body size in early life and risk of epithelial ovarian cancer: results from the Nurses’ Health Studies. Br J Cancer 99:1916–1922CrossRefPubMedPubMedCentral

go back to reference Sung J, Song YM, Lawlor DA, Smith GD, Ebrahim S (2009) Height and site-specific cancer risk: a cohort study of a korean adult population. Am J Epidemiol 170:53–64CrossRefPubMed Sung J, Song YM, Lawlor DA, Smith GD, Ebrahim S (2009) Height and site-specific cancer risk: a cohort study of a korean adult population. Am J Epidemiol 170:53–64CrossRefPubMed

go back to reference Engeland A, Tretli S, Bjørge T (2003) Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 95:1244–1248CrossRefPubMed Engeland A, Tretli S, Bjørge T (2003) Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 95:1244–1248CrossRefPubMed

go back to reference Chionh F, Baglietto L, Krishnan K, English DR, MacInnis RJ, Gertig DM, Hopper JL, Giles GG (2010) Physical activity, body size and composition, and risk of ovarian cancer. Cancer Causes Control 21:2183–2194CrossRefPubMed Chionh F, Baglietto L, Krishnan K, English DR, MacInnis RJ, Gertig DM, Hopper JL, Giles GG (2010) Physical activity, body size and composition, and risk of ovarian cancer. Cancer Causes Control 21:2183–2194CrossRefPubMed

go back to reference Lacey JV, Leitzmann M, Brinton LA, Lubin JH, Sherman ME, Schatzkin A, Schairer C (2006) Weight, height, and body mass index and risk for ovarian cancer in a cohort study. Ann Epidemiol 16:869–876CrossRefPubMed Lacey JV, Leitzmann M, Brinton LA, Lubin JH, Sherman ME, Schatzkin A, Schairer C (2006) Weight, height, and body mass index and risk for ovarian cancer in a cohort study. Ann Epidemiol 16:869–876CrossRefPubMed

go back to reference Lahmann PH, Cust AE, Friedenreich CM, Schulz M, Lukanova A, Kaaks R, Lundin E, Tjønneland A, Halkjaer J, Severinsen MT, Overvad K, Fournier A, Chabbert-Buffet N, Clavel-Chapelon F, Dossus L, Pischon T, Boeing H, Trichopoulou A, Lagiou P, Naska A, Palli D, Grioni S, Mattiello A, Tumino R, Sacerdote C, Redondo ML, Jakszyn P, Sánchez MJ, Tormo MJ, Ardanaz E, Arriola L, Manjer J, Jirström K, Bueno-de-Mesquita HB, May AM, Peeters PH, Onland-Moret NC, Bingham S, Khaw KT, Allen NE, Spencer E, Rinaldi S, Slimani N, Chajes V, Michaud D, Norat T, Riboli E (2010) Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 126:2404–2415PubMed Lahmann PH, Cust AE, Friedenreich CM, Schulz M, Lukanova A, Kaaks R, Lundin E, Tjønneland A, Halkjaer J, Severinsen MT, Overvad K, Fournier A, Chabbert-Buffet N, Clavel-Chapelon F, Dossus L, Pischon T, Boeing H, Trichopoulou A, Lagiou P, Naska A, Palli D, Grioni S, Mattiello A, Tumino R, Sacerdote C, Redondo ML, Jakszyn P, Sánchez MJ, Tormo MJ, Ardanaz E, Arriola L, Manjer J, Jirström K, Bueno-de-Mesquita HB, May AM, Peeters PH, Onland-Moret NC, Bingham S, Khaw KT, Allen NE, Spencer E, Rinaldi S, Slimani N, Chajes V, Michaud D, Norat T, Riboli E (2010) Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 126:2404–2415PubMed

go back to reference Weiderpass E, Sandin S, Inoue M, Shimazu T, Iwasaki M, Sasazuki S, Sawada N, Yamaji T, Tsugane S (2012) Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort. Int J Oncol 40:21–30PubMed Weiderpass E, Sandin S, Inoue M, Shimazu T, Iwasaki M, Sasazuki S, Sawada N, Yamaji T, Tsugane S (2012) Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort. Int J Oncol 40:21–30PubMed

go back to reference Kabat GC, Kim MY, Hollenbeck AR, Rohan TE (2014) Attained height, sex, and risk of cancer at different anatomic sites in the NIH-AARP diet and health study. Cancer Causes Control 25:1697–1706CrossRefPubMed Kabat GC, Kim MY, Hollenbeck AR, Rohan TE (2014) Attained height, sex, and risk of cancer at different anatomic sites in the NIH-AARP diet and health study. Cancer Causes Control 25:1697–1706CrossRefPubMed

go back to reference Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591CrossRefPubMed Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591CrossRefPubMed

go back to reference Renehan AG, Zwahlen M, Egger M (2015) Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer 15:484–498CrossRefPubMed Renehan AG, Zwahlen M, Egger M (2015) Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer 15:484–498CrossRefPubMed

go back to reference Byers T, Sedjo RL (2011) Does intentional weight loss reduce cancer risk? Diabetes Obes Metab 13:1063–1072CrossRefPubMed Byers T, Sedjo RL (2011) Does intentional weight loss reduce cancer risk? Diabetes Obes Metab 13:1063–1072CrossRefPubMed

go back to reference Fagherazzi G, Vilier A, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S (2012) Height, sitting height, and leg length in relation with breast cancer risk in the E3N cohort. Cancer Epidemiol Biomarkers Prev 21:1171–1175CrossRefPubMed Fagherazzi G, Vilier A, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S (2012) Height, sitting height, and leg length in relation with breast cancer risk in the E3N cohort. Cancer Epidemiol Biomarkers Prev 21:1171–1175CrossRefPubMed

go back to reference Praestegaard C, Jensen A, Jensen SM, Nielsen TS, Webb PM, Nagle CM, DeFazio A, Høgdall E, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, Edwards R, Matsuo K, Hosono S, Goode EL, Winham SJ, Fridley BL, Cramer DW, Terry KL, Schildkraut JM, Berchuck A, Bandera EV, Paddock LE, Massuger LF, Wentzensen N, Pharoah P, Song H, Whittemore A, McGuire V, Sieh W, Rothstein J, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike M, Lee AW, Sutphen R, Chang-Claude J, Risch HA, Kjaer SK, A.O.C.S. Group., O.C.A. Consortium (2017) Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies. Int J Cancer 140:2422–2435CrossRefPubMed Praestegaard C, Jensen A, Jensen SM, Nielsen TS, Webb PM, Nagle CM, DeFazio A, Høgdall E, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, Edwards R, Matsuo K, Hosono S, Goode EL, Winham SJ, Fridley BL, Cramer DW, Terry KL, Schildkraut JM, Berchuck A, Bandera EV, Paddock LE, Massuger LF, Wentzensen N, Pharoah P, Song H, Whittemore A, McGuire V, Sieh W, Rothstein J, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike M, Lee AW, Sutphen R, Chang-Claude J, Risch HA, Kjaer SK, A.O.C.S. Group., O.C.A. Consortium (2017) Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies. Int J Cancer 140:2422–2435CrossRefPubMed